⚠️ Research Use Only — Compounds discussed are research chemicals, not FDA-approved for human use. Not medical advice. Full disclaimers →
Also known as: HN, Humanin-G, S14G-Humanin
Humanin is a mitochondrial peptide research compound (not FDA-approved for human use) studied for neuroprotection. Humanin is a tiny peptide made by your mitochondria that protects cells from dying, shields the brain from Alzheimer's plaques, and improves insulin sensitivity. Blood levels drop dramatically with age. Research dose: 50–200 mcg daily. Half-life: 30 minutes. Available from COA-verified vendors with code PEPTIDEX for up to 20% off.
Sourcing data for Humanin is updating.
We verify new listings weekly — check back soon.
Sourcing data for Humanin is updating.
We verify new listings weekly — check back soon.
21-amino acid mitochondrial-derived peptide (MOTS-c sibling peptide) encoded in the 16S rRNA gene of mitochondrial DNA. Binds formyl peptide receptor-like 1 (FPRL1/FPR2) and the gp130 co-receptor comp
COA-verified vendors · Use code PEPTIDEX for up to 20% off
Verified pricing for Humanin is not yet available in our database. Browse all COA-verified vendors on our price comparison tool, or check individual vendor pages.
Compare All Vendors21-amino acid mitochondrial-derived peptide (MOTS-c sibling peptide) encoded in the 16S rRNA gene of mitochondrial DNA. Binds formyl peptide receptor-like 1 (FPRL1/FPR2) and the gp130 co-receptor complex, activating STAT3 and PI3K/Akt survival signaling. Potently inhibits Bax-mediated apoptosis, protects neurons against amyloid-beta toxicity, and improves insulin sensitivity. Circulating levels decline significantly with age.
Hashimoto et al. (Nature): Discovery paper identifying Humanin as a secreted peptide from surviving neurons that protects against Alzheimer's disease-related insults including amyloid-beta toxicity and familial AD gene expression.
PreclinicalMuzumdar et al.: Demonstrates that circulating Humanin levels decline progressively with age in humans, and low levels are associated with increased cardiovascular disease risk and insulin resistance.
EmergingMuzumdar et al.: Exogenous Humanin administration in rodents improves insulin sensitivity, reduces hepatic glucose production, and attenuates systemic inflammation, establishing its metabolic effects.
Preclinical⚠ PRECLINICAL RESEARCH ONLY for therapeutic use. No completed human clinical trials for exogenous administration. Endogenous peptide with well-established biology; exogenous therapeutic use remains experimental. S14G-Humanin is a more potent synthetic analog.
See our evidence grading methodology for how we evaluate and grade peptide safety data.
* Dosing data from published literature — not a human use recommendation.
No validated human dosing protocol. Rodent studies use 1–5mg/kg doses. Research use only.
Weeks 2–4
Rodent models show neuroprotection and metabolic improvement within 4 weeks
| Side Effect | Incidence | Severity |
|---|---|---|
Unknown in humans No human safety data for exogenous administration | Not established | rare |
Finding verified, high-purity Humanin requires rigorous COA verification. We independently evaluate vendors based on third-party HPLC testing, purity thresholds (≥98%), and batch-specific documentation.
View COA-Verified Humanin✓ Third-party tested·✓ US shipping·✓ COA on every batch
Disclosure: PeptiDex may earn a commission from purchases made through affiliate links. This does not affect our editorial independence or recommendations. We exclusively feature vendors that pass our strict quality verification protocols.
⚠️ Educational only · Not medical advice · For research use only. Information on this page is compiled from peer-reviewed literature and is intended strictly for educational and informational purposes. Peptides discussed may be unapproved research chemicals — consult a licensed healthcare professional before considering any peptide compound. Read our full disclaimer
Affiliate disclosure: PeptiDex may earn commissions from purchases made through vendor links on this page. This does not affect our editorial ranking or vendor recommendations — we exclusively feature vendors that pass independent COA verification. See our methodology · Editorial policy
12stacks • exact dosages • cycle lengths • printable reference
No spam. Unsubscribe anytime.
Independent researcher, not a medical professional
PeptiDex Research is the byline used by the independent researcher who builds and maintains PeptiDex. The site is a one-person research project — there is no editorial board, no medical reviewers, and no clinical staff. Content is produced by reading...
View profile